ODI PHARMA AB |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.7 SEK | 0.00% |
|
+4.59% | +14.00% |
| Feb. 22 | ODI Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 | CI |
| 2023 | ODI Pharma Sells CBD Skincare Brand for SEK3 Million | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Odi Pharma AB (publ) is a Swedish-based pharmaceutical company. The Company is a manufacturer and supplier of medical cannabis products. The business is run through subsidiaries and partners where sales are through wholesale distributors and pharmacies. The products are used for the treatment of, for example, multiple sclerosis, chronic pain and chemotherapy. The Company is located in Stockholm.
Sector
Pharmaceuticals
Calendar
2024-05-29
- Q3 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| +14.00% | 7.91M | |
| +26.63% | 661B | |
| +27.46% | 566B | |
| -6.36% | 352B | |
| +20.47% | 332B | |
| +3.49% | 283B | |
| +14.37% | 231B | |
| +5.24% | 200B | |
| -9.04% | 195B | |
| -4.88% | 145B |
- Stock Market
- Equities
- ODI Stock
- News ODI Pharma AB
- ODI Pharma Sells CBD Skincare Brand for SEK3 Million
